Iliana Bednarova MD, Presenter: Nothing to Disclose

Sandra Bednarova MD, Abstract Co-Author: Nothing to Disclose

Anna Linda MD, Abstract Co-Author: Nothing to Disclose

Viviana Londero MD, Abstract Co-Author: Nothing to Disclose

Chiara Zuiani MD, Abstract Co-Author: Nothing to Disclose

Massimo Bazzocchi MD, Abstract Co-Author: Nothing to Disclose

The application of DWI and ADC in pre-operative breast MRI might be a promising diagnostic tool for the differentiation of benign from metastatic axillary lymph nodes in patients with breast cancer.

1. The role of breast MRI in the assessment of axillary lymph nodes in breast cancer - morphologic criteria - cortical thickening, loss of fatty hilum, shape, size - enhancement - homogeneus, heterogeneus, rim-enhancement 2. The application of DWI and ADC in predicting axillary lymph nodes status - normal/reactive lymph node features - metastatic axillary lymph node features - the role of DWI and ADC in predicting lymph node status in malignant breast lesions - personal experience with case examples - diagnostic pitfalls - literature review on sensitivity and specificity of DWI and ADC in the assessment of lymph node status in patients with breast cancer  

http://abstract.rsna.org/uploads/2014/14011490/14011490_k1zh.pdf

Bednarova, I, Bednarova, S, Linda, A, Londero, V, Zuiani, C, Bazzocchi, M, Added Value of Pre-operative Diffusion-weighted Imaging (DWI) and Apparent Diffusion Coefficient (ADC) Ratio in Predicting Axillary Lymph Node Status in Patients with Breast Cancer: Literature Review and Personal Experience.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14011490.html